Vall d'Hebron Institute of Oncology (VHIO)

At VHIO we keep translating knowledge into real benefits, into health, quality of life, and opportunities for people Working hard to gain ground against cancer, we believe in what we do. With: Vall d'Hebron Barcelona Hospital Campus SOMM Alliance ICERCA - Centres de Recerca de Catalunya #precisionmedicine #oncology #translationalresearch #PreclinicalResearch #ClinicalResearch

How to interpret genomic testing results? The newly published ESMO Recommendations on clinical reporting of genomics test results for #SolidCancers aim at harmonising results between different laboratories and facilitate clinical decision-making for physicians. To make the most out of large amounts of data generated in oncology, the ESMO Precision Medicine Working Group developed a set of recommendations to facilitate comprehension of genomics reports beyond technicalities. 👇 To learn more, read the #ESMODailyReporter article  https://lnkd.in/dQMAt7FJ Joaquin Mateo

🔬 #Investigación| La investigación, dirigida desde el Vall d'Hebron Institute of Oncology (VHIO), combina un agonista de CD40 con quimioterapia en pacientes con adenocarcinoma ductal pancreático avanzado 👩⚕️ Dra. Teresa Macarulla: “Podemos hablar de resultados prometedores que abren la puerta a investigar esta combinación en un ensayo clínico fase 3 para validar su eficacia en un mayor número de pacientes” American Society of Clinical Oncology (ASCO) The Lancet ESMO - European Society for Medical Oncology #cáncer #cáncerdepáncreas #ensayosclínicos

🗞️ Published in Cell Press, a VHIO-led study shows that a novel liquid biopsy methodology enables the monitoring of disease evolution in patients with metastatic #ProstateCancer. 👨🔬 “Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course of disease,” says Joaquin Mateo, Medical Oncologist at the Vall d'Hebron Barcelona Hospital Campus and Corresponding Author of this VHIO-led study. 👩🔬 “However, the potential of tumor extracellular vesicles as a source of clinically relevant DNA and RNA biomarkers remains largely unexplored. We have now developed a new liquid biopsy application for the analysis of circulating vesicles secreted by cancer cells and performed multi-omic profiling for the genomic and transcriptomic characterization of these tumors,” explains Irene Casanova Salas, First Author of this Report article. 🔬 This work was mainly supported by funding received from the Fundación ”la Caixa”, Fundación Fero & CRIS contra el Cáncer Spanish National Cancer Research Centre (CNIO) | Centro de Investigación Príncipe Felipe (CIPF) #LiquidBiopsy #CancerResearch #ClinicalResearch #Biomarkers #TherapyResponse

¿Qué es una resonancia magnética? ¿Qué información nos proporciona sobre los tumores? ¿Cómo podemos utilizar esa información para desarrollar nuevas estrategias contra el cáncer? ¿Podría la inteligencia artificial ayudarnos a lograrlo? 👨🔬 Francesco Grussu, Carlos Macarro Pérez y Alonso García Ruiz, investigadores del Grupo de Radiómica del VHIO, responden a estas preguntas 👇 ➡️ https://lnkd.in/dwRJNvcD #InteligenciaArtificial #ResonanciaMagnética #SOMMVHIO #InvestigaciónContraElCáncer #Ciencia #RadiómicaVHIO #VHIO | SOMM Alliance

📣 Reserva't el dia ‼️ 👩⚕️ 🎙️ Dimarts vinent, 9 de juliol, Bianca Pont Cano, directora de Comunicació de VHIO, entrevista a Cristina Suárez, oncòloga Vall d'Hebron Barcelona Hospital Campus i investigadora del Programa de Tumors Genitourinaris del SNC i Sarcoma de VHIO. 🔴 En directe ➡️ https://lnkd.in/dXAA5AM8 #CàncerRenal

Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) i 9️⃣ instituts de recerca, entre ells el #VHIO, presenten la guia "Recomanacions per una comunicació inclusiva en la recerca en salut" per fomentar un llenguatge inclusiu en la investigació en salut. Descobreix-la ➡️ https://lnkd.in/dYrc-iyr #JoSocHipàtia ICERCA - Centres de Recerca de Catalunya | IRB Barcelona | Instituto Hospital del Mar de Investigaciones Médicas (IMIM) | Institut d'Investigació Biomèdica de Girona (IDIBGI) | Germans Trias i Pujol Research Institute (IGTP) | Josep Carreras Leukaemia Research Institute | Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré - IRBLLEIDA | Institut de Recerca Sant Pau

📣 Join us for the second #PhDDay #VHIR #VHIO ‼️ This exciting event is open to everyone with a special focus on the #PhDCommunity. 🗓️ July 12th ⏰ 9 AM 📍 Vall d'Hebron Barcelona Hospital Campus Check out the program ➡️ https://lnkd.in/dVPk-Wmz Fill out the registration form 👉 https://lnkd.in/dUjajxH2 Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca | ICERCA - Centres de Recerca de Catalunya

Novel immunotherapy in combination with chemotherapy shows promise in metastatic pancreatic cancer. 🗞️ The data was recently published in The Lancet Oncology and Teresa Macarulla is presenting an update today at #ESMOGI24. 👩🔬 “Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and carries a very poor prognosis. Despite significant advances in systemic therapy, median overall survival in de novo metastatic disease is still less than one year. Developing more effective treatment strategies to combat this highly complex and aggressive malignancy represents an urgent, unmet clinical need,” says Teresa Macarulla, a Medical Oncologist at Vall d'Hebron Barcelona Hospital Campus, Head of #VHIO’s Upper Gastrointestinal andEndocrine Tumors Group, and senior author of this study. ➡️ https://lnkd.in/d3kRcG2p #CancerResearch #Oncology #PancreaticCancer #Immunotherapy #Chemotherapy #TheLancetOncology #ESMOGI24 #VHIO 

Des de #VHIO ens comprometem a donar suport i protecció als drets del col·lectiu de persones lesbianes, gais, bisexuals, transgènere, intersexual, queer i d’altres identitats relacionades, i garantirem tolerància zero envers qualsevol tipus de discriminació, assetjament o violència contra aquest col·lectiu, tal i com fa amb la resta de col·lectius que formen part de la nostra institució. Enllaç declaració institucional ➡️ https://lnkd.in/dbGmBF_r Desde #VHIO nos comprometemos con la diversidad y la igualdad en una declaración institucional en la que el centro se compromete a dar apoyo y protección a los derechos del colectivo de personas lesbianas, gais, bisexuales, transgénero, intersexuales, queers y otras identidades relacionadas, y garantizaremos tolerancia cero hacia cualquier tipo de discriminación, acoso o violencia contra este colectivo, tal y como hace con el resto de los colectivos que forman parte de nuestra institución. Enlace declaración institucional ➡️ https://lnkd.in/dagq6Uq4 From #VHIO we are committed to providing support and protection for the rights of people who are lesbian, gay, bisexual, transgender, intersex, queer or other related identities, and will guarantee zero tolerance towards any type of discrimination, harassment or violence against this group, as it does with all other groups that form part of our institution. You can read the complete institutional declaration in this link ➡️ https://lnkd.in/dWbvk-yc #Diversity #Inclusion #LGBTQ #Equality #ZeroTolerance #Support #Protection #VHIO #InstitutionalCommitment #HumanRights